Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; Ryan D. Cassaday, MD; and Bijal D. Shah, MD, share their closing thoughts on where treatment for acute lymphoblastic leukemia is heading and what needs to be addressed in the future to achieve the optimal care for patients.

The panelists provide their concluding thoughts on the future management of acute lymphoblastic leukemia, given recent evolutions in therapy.

In this segment, Dan Douer, MD, and Mark R. Litzow, MD, discuss vincristine sulfate liposome injection, Marqibo.

The panelists, Raoul Tibes, MD, PhD, Stefan Faderl, MD, and Bijal D. Shah, MD, introduce emerging therapeutic alternatives to chemotherapy in the treatment of acute lymphoblastic leukemia.

In this session, Dr. David Szwajcer provided an overview of ALL, discussed the current treatment options, how to minimize the impact and side effects of treatment, and how research is opening new treatment avenues.

At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, Frankfurt, Germany, discusses the possibilities of immunotherapy for the treatment of patients with acute lymphoblastic leukemia.

R.J. Agostinelli was diagnosed with acute lymphoblastic Leukemia (ALL) in the summer of 2008. After months of treatment, he is finally ready to go back to school as a fifth grader. Listen as he tells his amazing story!